Therapeutic effects of IkB kinase inhibitor during systemic inflammation

Immunology and Microbiology

• Body Weight 33%
• Complement Factor B 66%
• Enzyme Blood Level 33%
• Gene Expression Assay 33%
• Hemodynamic 33%
• Inflammation Response 33%
• Inflammatory Disorder 33%
• Interleukin 6 33%
• Interleukin-1 33%
• Kidney Function 33%
• Liver Function 33%
• Muscle Function 33%
• Pancreas Function 33%
• Proinflammatory Cytokine 33%
• Rat Model 33%
• Reverse Transcription Polymerase Chain Reaction 33%
• Systemic Inflammation 100%
• Tumor Necrosis Factor 33%
• Vein 66%
• Wistar Rat 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Alternative Complement Pathway C3 C5 Convertase 50%
• Cytokine 25%
• Endotoxin 25%
• Inflammation 100%
• Inflammatory Disease 25%
• Interleukin 6 25%
• Lipopolysaccharide 25%
• Lipopolysaccharide-Induced Inflammation 25%
• Nuclear Factor 50%
• Phosphotransferase 50%
• Phosphotransferase Inhibitor 100%
• Rat Model 25%
• Therapeutic Effect 100%
• Tumor Necrosis Factor 25%
• Wistar Rat 25%